GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Other Income (Expense)

Aelis Farma (XPAR:AELIS) Other Income (Expense) : €1.13 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Other Income (Expense)?

Aelis Farma's other income expense for the Aelis Farma's pretax income for the six months ended in Dec. 2023 was €0.39 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was €1.13 Mil.


Aelis Farma Other Income (Expense) Historical Data

The historical data trend for Aelis Farma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Other Income (Expense) Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial -0.08 -0.07 -0.65 -5.70 1.13

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.23 -5.67 -0.03 0.74 0.39

Aelis Farma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aelis Farma  (XPAR:AELIS) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines